Chairman and CEO of Jazz Pharmaceuticals Inc. (JAZZ, Financial) Bruce C Cozadd buys 10,000 shares of JAZZ on 08/31/2010 at an average price of $8.6 a share.
Jazz Pharmaceuticals Inc. has a market cap of $343.8 million; its shares were traded at around $8.92 with a P/E ratio of 21.7 and P/S ratio of 2.6.
JAZZ is in the portfolios of Bruce Kovner of Caxton Associates.
Jazz Pharmaceuticals Inc. has a market cap of $343.8 million; its shares were traded at around $8.92 with a P/E ratio of 21.7 and P/S ratio of 2.6.
JAZZ is in the portfolios of Bruce Kovner of Caxton Associates.
Directors and Officers Recent Trades:
- Buy: Director Patrick G Enright bought 838,323 shares of JAZZ stock on 05/11/2010 at the average price of 8.35. Patrick G Enright owns at least 2,884,057 shares after this. The price of the stock has increased by 6.83% since.
- Sell: President Robert M Myers sold 15,000 shares of JAZZ stock on 03/09/2010 at the average price of 11.46. Robert M Myers owns at least 137,923 shares after this. The price of the stock has decreased by 22.16% since.
- Sell: SVP, GC and Secretary Carol A Gamble sold 14,467 shares of JAZZ stock on 03/09/2010 at the average price of 11.41. Carol A Gamble owns at least 18,492 shares after this. The price of the stock has decreased by 21.82% since.
